{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:35Z","timestamp":1791247955076,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00955-7","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:01:59Z","timestamp":1791183719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A critical appraisal of structure-based virtual screening, binding free energy methods, and AI-driven molecular design across the evolving computational landscape of drug discovery"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6794-4749","authenticated-orcid":false,"given":"Oluwaseun E.","family":"Agboola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Agboola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odunayo Selimot","family":"Adedeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temitope C.","family":"Aribigbola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olutosin S.","family":"Ilesanmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babasola","family":"Aiyeku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"955_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.biophys.36.040306.132550","volume":"36","author":"MK Gilson","year":"2007","unstructured":"Gilson MK, Zhou H-X (2007) Calculation of protein-ligand binding affinities. Annu Rev Biophys Biomol Struct 36:21\u201342. https:\/\/doi.org\/10.1146\/annurev.biophys.36.040306.132550","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"955_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.drudis.2008.07.005","volume":"13","author":"E Freire","year":"2008","unstructured":"Freire E (2008) Do enthalpy and entropy distinguish first in class from best in class? Drug Discov Today 13:869\u2013874. https:\/\/doi.org\/10.1016\/j.drudis.2008.07.005","journal-title":"Drug Discov Today"},{"key":"955_CR3","unstructured":"Shionogi & Co., Ltd. Xocova (ensitrelvir fumaric acid) tablets 125\u00a0mg approved in Japan under the emergency regulatory approval system, 22 November 2022; standard approval obtained 5 March 2024. Company announcements. https:\/\/www.shionogi.com\/global\/en\/news\/2024\/03\/20240305.html"},{"key":"955_CR4","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","volume":"65","author":"Y Unoh","year":"2022","unstructured":"Unoh Y, Uehara S, Nakahara K, Nobori H, Yamatsu Y, Yamamoto S, Maruyama Y, Taoda Y, Kasamatsu K, Suto T et al (2022) Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19. J Med Chem 65:6499\u20136512. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00117","journal-title":"J Med Chem"},{"key":"955_CR5","doi-asserted-by":"publisher","first-page":"15961","DOI":"10.3390\/ijms232415961","volume":"23","author":"H Zhu","year":"2022","unstructured":"Zhu H, Zhang Y, Li W, Huang (2022) N. A comprehensive survey of prospective structure-based virtual screening for early drug discovery in the past fifteen years. Int J Mol Sci 23:15961. https:\/\/doi.org\/10.3390\/ijms232415961","journal-title":"Int J Mol Sci"},{"key":"955_CR6","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1038\/s41591-025-03743-2","volume":"31","author":"Z Xu","year":"2025","unstructured":"Xu Z, Ren F, Wang P, Lin S, Liu Y, Zhang H, Chen S, Chai H, Kuang M, Greenberg D et al (2025) A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial. Nat Med 31:2602\u20132610. https:\/\/doi.org\/10.1038\/s41591-025-03743-2","journal-title":"Nat Med"},{"key":"955_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","volume":"566","author":"J Lyu","year":"2019","unstructured":"Lyu J, Wang S, Balius TE, Singh I, Levit A, Moroz YS, O\u2019Meara MJ, Che T, Algaa E, Tolmachova K et al (2019) Ultra-large library docking for discovering new chemotypes. Nature 566:224\u2013229. https:\/\/doi.org\/10.1038\/s41586-019-0917-9","journal-title":"Nature"},{"key":"955_CR8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41589-024-01797-w","volume":"21","author":"F Liu","year":"2025","unstructured":"Liu F, Mailhot O, Glenn IS, Vigneron SF, Bassim V, Xu X, Fonseca-Valencia K, Smith MS, Radchenko DS, Fraser JS et al (2025) The impact of library size and scale of testing on virtual screening. Nat Chem Biol 21:1039\u20131045. https:\/\/doi.org\/10.1038\/s41589-024-01797-w","journal-title":"Nat Chem Biol"},{"key":"955_CR9","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1021\/acs.jcim.0c00900","volume":"60","author":"CEM Schindler","year":"2020","unstructured":"Schindler CEM, Baumann H, Blum A, Bose D, Buchstaller H-P, Burgdorf L, Cappel D, Chekler E, Czodrowski P, Dorsch D et al (2020) Large-scale assessment of binding free energy calculations in active drug discovery projects. J Chem Inf Model 60:5457\u20135474. https:\/\/doi.org\/10.1021\/acs.jcim.0c00900","journal-title":"J Chem Inf Model"},{"key":"955_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2174\/1386207013330661","volume":"4","author":"J \u00c5qvist","year":"2001","unstructured":"\u00c5qvist J, Marelius J (2001) The linear interaction energy method for predicting ligand binding free energies. Comb Chem High Throughput Screen 4:613\u2013626. https:\/\/doi.org\/10.2174\/1386207013330661","journal-title":"Comb Chem High Throughput Screen"},{"key":"955_CR11","doi-asserted-by":"publisher","DOI":"10.1101\/2025.04.07.647682","author":"H Zheng","year":"2025","unstructured":"Zheng H, Lin H, Alade AA, Chen J, Monroy EY, Zhang M, Wang J (2025) AlphaFold3 in drug discovery: a comprehensive assessment of capabilities, limitations, and applications. bioRxiv. https:\/\/doi.org\/10.1101\/2025.04.07.647682. preprint; not peer reviewed at the time of writing","journal-title":"bioRxiv"},{"key":"955_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s42452-025-08111-w","volume":"8","author":"OE Agboola","year":"2026","unstructured":"Agboola OE, Agboola SS, Oyebamiji AK et al (2026) Computational discovery of microalgal metabolites as dual-target inhibitors against Plasmodium falciparum glutathione S-transferase and apical membrane antigen 1 for resistance-circumventing antimalarial therapy. Discov Appl Sci 8:106. https:\/\/doi.org\/10.1007\/s42452-025-08111-w","journal-title":"Discov Appl Sci"},{"key":"955_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/genes16050546","volume":"16","author":"OE Agboola","year":"2025","unstructured":"Agboola OE, Agboola SS, Oyinloye OM, Ayinla ZA, Osunsanmi FO, Olojo FO, Ajiboye BO (2025) Integrative genomic and in silico analysis reveals mitochondrially encoded cytochrome c oxidase III (MT-CO3) overexpression and potential neem-derived inhibitors in breast cancer. Genes 16:546. https:\/\/doi.org\/10.3390\/genes16050546","journal-title":"Genes"},{"key":"955_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41589-022-01234-w","volume":"19","author":"J Lyu","year":"2023","unstructured":"Lyu J, Irwin JJ, Shoichet BK (2023) Modeling the expansion of virtual screening libraries. Nat Chem Biol 19:712\u2013718. https:\/\/doi.org\/10.1038\/s41589-022-01234-w","journal-title":"Nat Chem Biol"},{"key":"955_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/2023.04.25.537981","author":"C Gorgulla","year":"2023","unstructured":"Gorgulla C, Nigam A, Koop M, Cinaroglu SS, Secker C, Haddadnia M, Kumar A, Malets Y, Hasson A, Li M et al (2023) VirtualFlow 2.0: the next generation drug discovery platform enabling adaptive screens of 69 billion molecules. bioRxiv. https:\/\/doi.org\/10.1101\/2023.04.25.537981. preprint; not peer reviewed at the time of writing","journal-title":"bioRxiv"},{"key":"955_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C et al (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582:289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"key":"955_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1039\/D2SC05709C","volume":"14","author":"F Ren","year":"2023","unstructured":"Ren F, Ding X, Zheng M, Korzinkin M, Cai X, Zhu W, Mantsyzov A, Aliper A, Aladinskiy V, Cao Z et al (2023) AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor. Chem Sci 14:1443\u20131452. https:\/\/doi.org\/10.1039\/D2SC05709C","journal-title":"Chem Sci"},{"key":"955_CR18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1021\/acs.accounts.7b00083","volume":"50","author":"R Abel","year":"2017","unstructured":"Abel R, Wang L, Harder ED, Berne BJ, Friesner RA (2017) Advancing drug discovery through enhanced free energy calculations. Acc Chem Res 50:1625\u20131632. https:\/\/doi.org\/10.1021\/acs.accounts.7b00083","journal-title":"Acc Chem Res"},{"key":"955_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"955_CR20","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J, Wang Z, Liu H, Zhang JZH, Hou T (2019) End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev 119:9478\u20139508. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00055","journal-title":"Chem Rev"},{"key":"955_CR21","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/ja512751q","volume":"137","author":"L Wang","year":"2015","unstructured":"Wang L, Wu Y, Deng Y, Kim B, Pierce L, Krilov G, Lupyan D, Robinson S, Dahlgren MK, Greenwood J et al (2015) Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J Am Chem Soc 137:2695\u20132703. https:\/\/doi.org\/10.1021\/ja512751q","journal-title":"J Am Chem Soc"},{"key":"955_CR22","doi-asserted-by":"publisher","first-page":"16829","DOI":"10.1038\/s41598-019-53133-1","volume":"9","author":"F Fratev","year":"2019","unstructured":"Fratev F, Sirimulla S (2019) An improved free energy perturbation FEP+ sampling protocol for flexible ligand-binding domains. Sci Rep 9:16829. https:\/\/doi.org\/10.1038\/s41598-019-53133-1","journal-title":"Sci Rep"},{"key":"955_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s42004-023-01019-9","volume":"6","author":"GA Ross","year":"2023","unstructured":"Ross GA, Lu C, Scarabelli G, Albanese SK, Houang E, Abel R, Harder ED, Wang L (2023) The maximal and current accuracy of rigorous protein-ligand binding free energy calculations. Commun Chem 6:222. https:\/\/doi.org\/10.1038\/s42004-023-01019-9","journal-title":"Commun Chem"},{"key":"955_CR24","doi-asserted-by":"publisher","first-page":"101695","DOI":"10.1016\/j.nexres.2026.101695","volume":"9","author":"OE Agboola","year":"2026","unstructured":"Agboola OE, Olusola OS, Agboola SS, Adedeji OS, Aribigbola TC, Umoekam AS, Ayinla ZA, Ilesanmi OS, Omotuyi IO, Oyinloye BE, Aiyeku B (2026) Computational identification of marine microalgal metabolites as human voltage-dependent anion channel 1 modulators: virtual screening, DFT analysis, molecular dynamics simulation, and machine learning-supported cheminformatic validation. Next Res 9:101695. https:\/\/doi.org\/10.1016\/j.nexres.2026.101695","journal-title":"Next Res"},{"key":"955_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s44187-025-00441-3","volume":"5","author":"BE Oyinloye","year":"2025","unstructured":"Oyinloye BE, Agboola OE, Ayeni AM et al (2025) Computational analysis of Annona muricata phytochemicals for targeted modulation of endocrine networks in polycystic ovary syndrome. Discov Food 5:145. https:\/\/doi.org\/10.1007\/s44187-025-00441-3","journal-title":"Discov Food"},{"key":"955_CR26","doi-asserted-by":"publisher","first-page":"112651","DOI":"10.1016\/j.rineng.2026.112651","volume":"32","author":"OE Agboola","year":"2026","unstructured":"Agboola OE, Agboola SS, Aribigbola TC, Shaleye AB, Adedeji OS, Ayinla ZA, Omotuyi IO (2026) Ranking metrics conceal pose errors in blind docking with AutoDock Vina, a cross-target benchmark. Results Eng 32:112651. https:\/\/doi.org\/10.1016\/j.rineng.2026.112651","journal-title":"Results Eng"},{"key":"955_CR27","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK et al (2004) Glide: a new approach for rapid, accurate docking and scoring. J Med Chem 47:1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"955_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"955_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13321-025-00973-x","volume":"17","author":"AT McNutt","year":"2025","unstructured":"McNutt AT, Li Y, Meli R, Aggarwal R, Koes DR (2025) GNINA 1.3: the next increment in molecular docking with deep learning. J Cheminform 17:28. https:\/\/doi.org\/10.1186\/s13321-025-00973-x","journal-title":"J Cheminform"},{"key":"955_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J et al (2024) Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630:493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w","journal-title":"Nature"},{"key":"955_CR31","volume-title":"The Nobel Prize in Chemistry 2024","author":"Royal Swedish Academy of Sciences","year":"2024","unstructured":"Royal Swedish Academy of Sciences (2024) The Nobel Prize in Chemistry 2024. Stockholm, Sweden. https:\/\/www.nobelprize.org\/prizes\/chemistry\/2024"},{"key":"955_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727\u2013730. https:\/\/doi.org\/10.1038\/nrd892","journal-title":"Nat Rev Drug Discov"},{"key":"955_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.10.615955","author":"Chai Discovery Team","year":"2024","unstructured":"Chai Discovery Team (2024) Chai-1: decoding the molecular interactions of life. bioRxiv. https:\/\/doi.org\/10.1101\/2024.10.10.615955. preprint; not peer reviewed at the time of writing","journal-title":"bioRxiv"},{"key":"955_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/2024.11.19.624167","author":"J Wohlwend","year":"2024","unstructured":"Wohlwend J, Corso G, Passaro S, Reveiz M, Leidal K, Swiderski W, Portnoi T, Chinn I, Silterra J, Jaakkola T, Barzilay R (2024) Boltz-1: democratizing biomolecular interaction modeling. bioRxiv. https:\/\/doi.org\/10.1101\/2024.11.19.624167. preprint; not peer reviewed at the time of writing","journal-title":"bioRxiv"},{"key":"955_CR35","unstructured":"ByteDance Protenix Team. Protenix: an open-source reproduction of AlphaFold3. GitHub repository (2024) https:\/\/github.com\/bytedance\/Protenix"},{"key":"955_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.14.659707","author":"S Passaro","year":"2025","unstructured":"Passaro S, Corso G, Wohlwend J, Reveiz M, Thaler S, Somnath VR, Getz N, Portnoi T, Roy J, Stark H et al (2025) Boltz-2: towards accurate and efficient binding affinity prediction. bioRxiv. https:\/\/doi.org\/10.1101\/2025.06.14.659707. preprint; not peer reviewed at the time of writing","journal-title":"bioRxiv"},{"key":"955_CR37","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1021\/acs.jcim.1c00744","volume":"61","author":"TM Creanza","year":"2021","unstructured":"Creanza TM, Delre P, Ancona N, Lentini G, Saviano M, Mangiatordi GF (2021) Structure-based prediction of hERG-related cardiotoxicity: a benchmark study. J Chem Inf Model 61:4758\u20134770. https:\/\/doi.org\/10.1021\/acs.jcim.1c00744","journal-title":"J Chem Inf Model"},{"key":"955_CR38","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1021\/acs.jcim.6c01038","volume":"66","author":"H Maidanik","year":"2026","unstructured":"Maidanik H, Lazou M, Bajaj R, Sarwar R, Ziaee O, Vajda S, Joseph-McCarthy D (2026) Assessment of AlphaFold protein models for small-molecule ligand docking versus co-folding. J Chem Inf Model 66:5811\u20135823. https:\/\/doi.org\/10.1021\/acs.jcim.6c01038","journal-title":"J Chem Inf Model"},{"key":"955_CR39","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1021\/acs.jcim.2c01219","volume":"63","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Vass M, Shi D, Abualrous E, Chambers JM, Chopra N, Higgs C, Kasavajhala K, Li H, Nandekar P et al (2023) Benchmarking refined and unrefined AlphaFold2 structures for hit discovery. J Chem Inf Model 63:1656\u20131667. https:\/\/doi.org\/10.1021\/acs.jcim.2c01219","journal-title":"J Chem Inf Model"},{"key":"955_CR40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1021\/acs.jcim.3c01761","volume":"64","author":"AA Bekar-Cesaretli","year":"2024","unstructured":"Bekar-Cesaretli AA, Khan O, Nguyen T, Kozakov D, Joseph-McCarthy D, Vajda S (2024) Conservation of hot spots and ligand binding sites in protein models by AlphaFold2. J Chem Inf Model 64:960\u2013973. https:\/\/doi.org\/10.1021\/acs.jcim.3c01761","journal-title":"J Chem Inf Model"},{"key":"955_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-023-00832-0","volume":"23","author":"A Tropsha","year":"2024","unstructured":"Tropsha A, Isayev O, Varnek A, Schneider G, Cherkasov A (2024) Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR. Nat Rev Drug Discov 23:141\u2013155. https:\/\/doi.org\/10.1038\/s41573-023-00832-0","journal-title":"Nat Rev Drug Discov"},{"key":"955_CR42","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","volume":"59","author":"K Yang","year":"2019","unstructured":"Yang K, Swanson K, Jin W, Coley C, Eiden P, Gao H, Guzman-Perez A, Hopper T, Kelley B, Mathea M et al (2019) Analyzing learned molecular representations for property prediction. J Chem Inf Model 59:3370\u20133388. https:\/\/doi.org\/10.1021\/acs.jcim.9b00237","journal-title":"J Chem Inf Model"},{"key":"955_CR43","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.1021\/acs.jmedchem.9b00959","volume":"63","author":"Z Xiong","year":"2020","unstructured":"Xiong Z, Wang D, Liu X, Zhong F, Wan X, Li X, Li Z, Luo X, Chen K, Jiang H et al (2020) Pushing the boundaries of molecular representation for drug discovery with the graph attention mechanism. J Med Chem 63:8749\u20138760. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00959","journal-title":"J Med Chem"},{"key":"955_CR44","doi-asserted-by":"publisher","unstructured":"Agboola OE, Agboola SS, Adegbuyi AT, Ayinla ZA (2026) Combined molecular fingerprint and descriptor features enable classical machine learning to match deep learning performance across the Tox21 toxicity panel. Toxicol Mech Methods 1\u201312. https:\/\/doi.org\/10.1080\/15376516.2026.2703006","DOI":"10.1080\/15376516.2026.2703006"},{"key":"955_CR45","doi-asserted-by":"publisher","unstructured":"Agboola OE, Agboola SS, Shaleye AB, Adedeji OS, Aribigbola TC, Oyinloye BE (2026) End-to-end multimodal attention fusion for drug-target interaction prediction with cold-scaffold validation on the Davis kinase benchmark. J Mol Graph Model 109461. https:\/\/doi.org\/10.1016\/j.jmgm.2026.109461","DOI":"10.1016\/j.jmgm.2026.109461"},{"key":"955_CR46","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1021\/acs.jcim.2c01073","volume":"62","author":"D van Tilborg","year":"2022","unstructured":"van Tilborg D, Alenicheva A, Grisoni F (2022) Exposing the limitations of molecular machine learning with activity cliffs. J Chem Inf Model 62:5938\u20135951. https:\/\/doi.org\/10.1021\/acs.jcim.2c01073","journal-title":"J Chem Inf Model"},{"key":"955_CR47","doi-asserted-by":"publisher","first-page":"110406","DOI":"10.1016\/j.bioorg.2026.110406","volume":"181","author":"SS Agboola","year":"2026","unstructured":"Agboola SS, Agboola OE, Olasehinde OR, Aribigbola TC, Shaleye AB, Alebiosu IA, Ayinla ZA, Oyinloye BE, Ilesanmi OS, Omotuyi IO, Oyebamiji AK (2026) Activity cliffs resist prediction within and across protein kinases: a leakage-controlled machine-learning analysis of structure-potency discontinuities. Bioorg Chem 181:110406. https:\/\/doi.org\/10.1016\/j.bioorg.2026.110406","journal-title":"Bioorg Chem"},{"key":"955_CR48","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1021\/acs.jcim.4c00049","volume":"64","author":"GA Landrum","year":"2024","unstructured":"Landrum GA, Riniker S (2024) Combining IC50 or Ki values from different sources is a source of significant noise. J Chem Inf Model 64:1560\u20131567. https:\/\/doi.org\/10.1021\/acs.jcim.4c00049","journal-title":"J Chem Inf Model"},{"key":"955_CR49","doi-asserted-by":"publisher","unstructured":"Agboola OE, Agboola SS, Adegbuyi AT, Ayinla ZA (2026) Synergistic, additive, and antagonistic modulation of inflammation and immunity by multi-compound traditional Chinese medicine formulas. Pharmacol Res Mod Chin Med 100816. https:\/\/doi.org\/10.1016\/j.prmcm.2026.100816","DOI":"10.1016\/j.prmcm.2026.100816"},{"key":"955_CR50","doi-asserted-by":"publisher","first-page":"100772","DOI":"10.1016\/j.prmcm.2026.100772","volume":"18","author":"OE Agboola","year":"2026","unstructured":"Agboola OE, Ayinla ZA, Agboola SS, Olaiya OE, Oyinloye BE (2026) Machine learning framework for multi-regulatory safety assessment of traditional Chinese medicine compounds. Pharmacol Res Mod Chin Med 18:100772. https:\/\/doi.org\/10.1016\/j.prmcm.2026.100772","journal-title":"Pharmacol Res Mod Chin Med"},{"key":"955_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s42452-026-09459-3","author":"OE Agboola","year":"2026","unstructured":"Agboola OE, Agboola SS, Shaleye AB et al (2026) Feature transferability and the lead configuration barrier in cross-database ventricular ectopy detection. Discov Appl Sci. https:\/\/doi.org\/10.1007\/s42452-026-09459-3","journal-title":"Discov Appl Sci"},{"key":"955_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s42004-025-01635-7","volume":"8","author":"I Filella-Merce","year":"2025","unstructured":"Filella-Merce I, Molina A, D\u00edaz L, Orzechowski M, Berchiche YA, Zhu YM, Vilalta-Mor J, Malo L, Yekkirala AS, Ray S, Guallar V (2025) Optimizing drug design by merging generative AI with a physics-based active learning framework. Commun Chem 8:238. https:\/\/doi.org\/10.1038\/s42004-025-01635-7","journal-title":"Commun Chem"},{"key":"955_CR53","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1038\/s41467-025-60629-0","volume":"16","author":"M Thomas","year":"2025","unstructured":"Thomas M, Matricon PG, Gillespie RJ, Napi\u00f3rkowska M, Neale H, Mason JS, Brown J, Harwood K, Fieldhouse C, Swain NA et al (2025) Identification of nanomolar adenosine A2A receptor ligands using reinforcement learning and structure-based drug design. Nat Commun 16:5485. https:\/\/doi.org\/10.1038\/s41467-025-60629-0","journal-title":"Nat Commun"},{"key":"955_CR54","doi-asserted-by":"publisher","unstructured":"Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A, Donghia NM, MacNair CR, French S, Carfrae LA, Bloom-Ackermann Z et al A deep learning approach to antibiotic discovery. Cell 2020, 180, 688\u2013702. https:\/\/doi.org\/10.1016\/j.cell.2020.01.021","DOI":"10.1016\/j.cell.2020.01.021"},{"key":"955_CR55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2204619","volume":"387","author":"PA Janne","year":"2022","unstructured":"Janne PA, Riely GJ, Gadgeel SM, Heist RS, Ou SI, Pacheco JM, Johnson ML, Sabari JK, Leventakos K, Yau E et al (2022) Adagrasib in non-small-cell lung cancer harboring a KRASG12C mutation. N Engl J Med 387:120\u2013131. https:\/\/doi.org\/10.1056\/NEJMoa2204619","journal-title":"N Engl J Med"},{"key":"955_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2159-8290.CD-19-1167","volume":"10","author":"J Hallin","year":"2020","unstructured":"Hallin J, Engstrom LD, Hargis L, Calinisan A, Aranda R, Briere DM, Sudhakar N, Bowcut V, Baer BR, Ballard JA et al (2020) The KRASG12C inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients. Cancer Discov 10:54\u201371. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1167","journal-title":"Cancer Discov"},{"key":"955_CR57","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395:e30\u2013e31. https:\/\/doi.org\/10.1016\/S0140-6736(20)30304-4","journal-title":"Lancet"},{"key":"955_CR58","doi-asserted-by":"publisher","first-page":"dlag146","DOI":"10.1093\/jacamr\/dlag146","volume":"8","author":"OE Agboola","year":"2026","unstructured":"Agboola OE, Agboola SS, Adekanle MA, Akinloye AO, Ayinla ZA, Fatukasi BA, Aribigbola TC, Umoekam AS, Oyeniran OA, Adenigba VO, Shaleye AB (2026) Global surveillance quality gaps in antimicrobial resistance monitoring: a composite-index and inequality analysis of 85 countries. JAC-Antimicrob Resist 8:dlag146. https:\/\/doi.org\/10.1093\/jacamr\/dlag146","journal-title":"JAC-Antimicrob Resist"},{"key":"955_CR59","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1021\/ci100176x","volume":"50","author":"D Fourches","year":"2010","unstructured":"Fourches D, Muratov E, Tropsha A (2010) Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf Model 50:1189\u20131204. https:\/\/doi.org\/10.1021\/ci100176x","journal-title":"J Chem Inf Model"},{"key":"955_CR60","doi-asserted-by":"publisher","unstructured":"Agboola OE, Agboola SS, Shaleye AB, Umoekam AS, Ayinla ZA, Olasehinde TY (2026) Integration of clinical pharmacokinetic database with compartmental modeling and regulatory data analysis. Curr Ther Res 100832. https:\/\/doi.org\/10.1016\/j.curtheres.2026.100832","DOI":"10.1016\/j.curtheres.2026.100832"},{"key":"955_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05785-w","author":"OE Agboola","year":"2026","unstructured":"Agboola OE, Agboola SS (2026) Artificial intelligence-driven cross-endpoint stacked ensemble learning for separate but meta-feature coupled prediction of six human pharmacokinetic endpoints with RDKit molecular representation and applicability domain control on real TDC benchmark data. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05785-w","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"955_CR62","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Felix E, Magarinos MP, Mosquera JF, Mutowo P, Nowotka M et al (2019) ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res 47:D930\u2013D940. https:\/\/doi.org\/10.1093\/nar\/gky1075","journal-title":"Nucleic Acids Res"},{"key":"955_CR63","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1021\/acs.jcim.3c00799","volume":"64","author":"W Heyndrickx","year":"2024","unstructured":"Heyndrickx W, Mervin L, Morawietz T, Sturm N, Friedrich L, Zalewski A, Pentina A, Humbeck L, Oldenhof M, Niwayama R et al (2024) MELLODDY: cross-pharma federated learning at unprecedented scale unlocks benefits in QSAR without compromising proprietary information. J Chem Inf Model 64:2331\u20132344. https:\/\/doi.org\/10.1021\/acs.jcim.3c00799","journal-title":"J Chem Inf Model"},{"key":"955_CR64","doi-asserted-by":"publisher","unstructured":"Adegbuyi AT, Olanlokun JO, Agboola OE, Agboola SS, Fajana OM, Aribigbola TC (2026) Machine learning-augmented network pharmacology prioritizes multi-target anti-inflammatory candidates from the n-hexane fraction of Alstonia boonei. Ind Crops Prod 254. https:\/\/doi.org\/10.1016\/j.indcrop.2026.123928","DOI":"10.1016\/j.indcrop.2026.123928"},{"key":"955_CR65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13321-022-00646-z","volume":"14","author":"M Thomas","year":"2022","unstructured":"Thomas M, O\u2019Boyle NM, Bender A, de Graaf C (2022) Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation. J Cheminform 14:68. https:\/\/doi.org\/10.1186\/s13321-022-00646-z","journal-title":"J Cheminform"},{"key":"955_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13321-024-00812-5","volume":"16","author":"HH Loeffler","year":"2024","unstructured":"Loeffler HH, He J, Tibo A, Janet JP, Voronov A, Mervin LH, Engkvist O (2024) REINVENT 4: modern AI-driven generative molecule design. J Cheminform 16:20. https:\/\/doi.org\/10.1186\/s13321-024-00812-5","journal-title":"J Cheminform"},{"key":"955_CR67","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.ade2574","volume":"379","author":"Z Lin","year":"2023","unstructured":"Lin Z, Akin H, Rao R, Hie B, Zhu Z, Lu W, Smetanin N, Verkuil R, Kabeli O, Shmueli Y et al (2023) Evolutionary-scale prediction of atomic-level protein structure with a language model. Science 379:1123\u20131130. https:\/\/doi.org\/10.1126\/science.ade2574","journal-title":"Science"},{"key":"955_CR68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ph17010022","volume":"17","author":"SK Niazi","year":"2024","unstructured":"Niazi SK, Mariam Z (2024) Computer-aided drug design and drug discovery: a prospective analysis. Pharmaceuticals 17:22. https:\/\/doi.org\/10.3390\/ph17010022","journal-title":"Pharmaceuticals"},{"key":"955_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharma.2025.08.001","author":"OE Agboola","year":"2025","unstructured":"Agboola OE, Agboola SS, Odeghe OB, Olaiya OE, Ayinla ZA, Akinsanya PO, Ilesanmi OS, Ibrahim TK, Adegbuyi TA, Kolawole OA et al (2025) Computational genome engineering through AI-CRISPR-precision medicine integration in modern therapeutics. Ann Pharm Fr. https:\/\/doi.org\/10.1016\/j.pharma.2025.08.001","journal-title":"Ann Pharm Fr"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00955-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00955-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00955-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:04:41Z","timestamp":1791245081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00955-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00955-7","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Statement: Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We used AI tools solely for linguistic refinement of this review report. The drafting, scientific judgment, criticisms, recommendations, and final responsibility for the content remain entirely our own as authors.","order":3,"name":"Ethics","label":"AI use statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":5,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"247"}}